Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 10/20 | 0.34 |
| ▸ | SELL | P14151 | 9/20 | 0.34 |
| ▸ | CETP | P11597 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | VEGFA | P15692 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9988845 | 1.00 | SELP (0.34) | SELPSELLCETPGAAVEGFA | |
| SCHEMBL19818078 | 1.00 | SELP (0.34) | SELPSELLCETPGAAVEGFA | |
| SCHEMBL27386943 | 1.00 | SELP (0.34) | SELPSELLCETPGAAVEGFA | |
| SCHEMBL4750606 | 1.00 | SELP (0.34) | SELPSELLCETPGAAVEGFA | |
| SCHEMBL8986520 | 0.82 | SELL (0.34) | SELPSELL | |
| SCHEMBL21356850 | 0.82 | CETP (0.46) | CETPGAA | |
| SCHEMBL21356839 | 0.82 | CETP (0.46) | CETPGAA | |
| SCHEMBL38975 | 0.82 | CETP (0.46) | CETPGAA | |
| SCHEMBL21356842 | 0.82 | CETP (0.46) | CETPGAA | |
| SCHEMBL21356851 | 0.82 | CETP (0.46) | CETPGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023275142-A1 | FRAGRANCED COSMETIC COMPOSITION COMPRISING AT LEAST ONE ORGANIC ACID ESTER, AN ANTHOCYANI(DI)N DYE AND A FRAGRANCING MATERIAL | L'OREAL (FR) | 2023-01-05 | — | — | WO | claimed |
| WO-2022144369-A1 | FRAGRANCED COSMETIC COMPOSITION COMPRISING AN ORGANIC ACID, A NATURAL ANTHOCYANI(DI)N DYE AND A FRAGRANCING MATERIAL, AND PROCESS FOR TREATING KERATIN MATERIALS AND/OR CLOTHING USING THE COMPOSITION | L'OREAL (FR) | 2022-07-07 | — | — | WO | claimed |
| US-20190281874-A1 | OLIGOSACCHARIDES FOR FLAVOUR GENERATION | Société des Produits Nestlé S.A. (CH) | 2019-09-19 | — | — | US | claimed |
| US-20260145365-A1 | METHOD AND DEVICE FOR PRODUCING A STABILIZER COMPOSITION IN GRANULATE FORM AND AN ACCORDINGLY PRODUCED STABILIZER COMPOSITION | AKDENIZ CHEMSON ADDITIVES A.G. (AT) | 2026-05-28 | — | — | US | disclosed |
| EP-4736654-A2 | OLIGOSACCHARIDES FOR FLAVOUR GENERATION | Société des Produits Nestlé S.A. (CH) | 2026-05-06 | — | — | EP | disclosed |
| US-20260071050-A1 | BIODEGRADABLE POLYMER COMPOSITIONS | INTERFACIAL CONSULTANTS LLC (US) | 2026-03-12 | — | — | US | disclosed |
| EP-4605200-A1 | METHOD AND DEVICE FOR PRODUCING A STABILIZER COMPOSITION IN GRANULATE FORM AND AN ACCORDINGLY PRODUCED STABILIZER COMPOSITION | Akdeniz Chemson Additives AG (AT) | 2025-08-27 | — | — | EP | disclosed |
| US-12371581-B2 | High performance water soluble polymer compositions | INTERFACIAL CONSULTANTS LLC | 2025-07-29 | — | — | US | disclosed |
| US-20250222060-A1 | POLYPHENOL COMPOSITION AND METHOD OF ITS USE AND MANUFACTURE IN REDUCING BODY WEIGHT | Vidya Herbs, Inc. (US) | 2025-07-10 | — | — | US | disclosed |
| CN-120076911-A | Method and device for producing a stabilizer composition in particulate form and stabilizer composition produced thereby | 阿登尼斯开米森添加剂股份公司 | 2025-05-30 | — | — | CN | disclosed |
| US-12226443-B2 | Polyphenol composition and method of its use and manufacture in the treatment of metabolic disorders | Vidya Herbs, Inc. (US) | 2025-02-18 | — | — | US | disclosed |
| US-20110311744-A1 | HEAVY METAL-FREE STABILIZER COMPOSITION FOR HALOGENATED POLYMERS | CHEMSON POLYMER-ADDITIVE AG (AT) | 2011-12-22 | — | — | US | disclosed |
| US-20110143068-A1 | STABILIZER COMPOSITION FOR HALOGEN-CONTAINING POLYMERS | AKDENIZ CHEMSON ADDITIVES AG (AT) | 2011-06-16 | — | — | US | disclosed |
| EP-2238967-A2 | Skin treatment fighting skin aging II | Henkel AG & Co. KGaA (DE) | 2010-10-13 | — | — | EP | disclosed |
| EP-2238968-A2 | Skin treatment fighting skin aging | Henkel AG & Co. KGaA (DE) | 2010-10-13 | — | — | EP | disclosed |
| EP-2223679-A2 | Cellular rejuvenation compounds | Henkel AG & Co. KGaA (DE) | 2010-09-01 | — | — | EP | disclosed |
| WO-2010072754-A1 | HYDROSOLUBLE [6)O-α-D-GLCP-(1→]n-6-O-β-D-GLCP-(1→-PHENOLIC DERIVATIVES WITH DERMOCOSMETIC, NUTRITIONAL AND THERAPEUTIC APPLICATIONS, AND COMPOSITIONS CONTAINING SAID WATER SOLUBLE COMPOUNDS | LIBRAGEN (FR) | 2010-07-01 | — | — | WO | disclosed |
| EP-2202237-A1 | Hydrosoluble [6)-O-alpha-d-glcp-(1->]n-6-o-bêta-d-glcp-(1->-phenllic derivatives with dermocosmetic, nutritional and therapeutic applications, and compositions containing said water soluble compounds | Libragen (FR) | 2010-06-30 | — | — | EP | disclosed |
| EP-2005941-A2 | Cellular rejuvenation compounds | Henkel AG & Co. KGaA (DE) | 2008-12-24 | — | — | EP | disclosed |
| US-20080269082-A1 | DELAYED HYDROCARBON GEL CROSSLINKERS AND METHODS FOR MAKING AND USING SAME | CLEARWATER INTERNATIONAL, LLC (US) | 2008-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260145365-A1 | METHOD AND DEVICE FOR PRODUCING A STABILIZER COMPOSITION IN GRANULATE FORM AND AN ACCORDINGLY PRODUCED STABILIZER COMPOSITION | GRN, IL36G, GMNN | SELP 1296/4885SELL 1218/4885CETP 1887/4885 |
| US-20260071050-A1 | BIODEGRADABLE POLYMER COMPOSITIONS | PGD, MPDU1, MGAM | SELP 516/4885SELL 3310/4885CETP 1182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.